Myeloid Nrf2 deficiency aggravates non-alcoholic steatohepatitis progression by regulating YAP-mediated NLRP3 inflammasome signaling
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Myeloid Nrf2 deficiency aggravates non-alcoholic steatohepatitis progression by regulating YAP-mediated NLRP3 inflammasome signaling
Authors
Keywords
-
Journal
iScience
Volume 24, Issue 5, Pages 102427
Publisher
Elsevier BV
Online
2021-04-19
DOI
10.1016/j.isci.2021.102427
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism
- (2020) Marie Angèle Cucci et al. FREE RADICAL BIOLOGY AND MEDICINE
- Macrophage achieves self-protection against oxidative stress-induced ageing through the Mst-Nrf2 axis
- (2019) Ping Wang et al. Nature Communications
- Hippo signaling controls NLRP 3 Activation and governs immunoregulation of mesenchymal stem cells in mouse liver injury
- (2019) Changyong Li et al. HEPATOLOGY
- Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury
- (2019) Yuan Liu et al. JOURNAL OF HEPATOLOGY
- HEATR1 deficiency promotes pancreatic cancer proliferation and gemcitabine resistance by up-regulating Nrf2 signaling
- (2019) Yunjiang Zhou et al. Redox Biology
- Nrf2-Keap1 signaling in oxidative and reductive stress
- (2018) Ilaria Bellezza et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- NRF2 and the Hallmarks of Cancer
- (2018) Montserrat Rojo de la Vega et al. CANCER CELL
- Emerging roles of Hippo signaling in inflammation and YAP-driven tumor immunity
- (2018) Yuhang Zhou et al. CANCER LETTERS
- Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation
- (2018) Samar H Ibrahim et al. GUT
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
- (2018) Chris Estes et al. JOURNAL OF HEPATOLOGY
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Specialized Proresolving Mediators: Enhancing Nonalcoholic Steatohepatitis and Fibrosis Resolution
- (2018) Giovanni Musso et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Modulating NRF2 in Disease: Timing Is Everything
- (2018) Matthew Dodson et al. Annual Review of Pharmacology and Toxicology
- The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
- (2018) Konstantin Kazankov et al. Nature Reviews Gastroenterology & Hepatology
- NLRP3 Deletion Inhibits the Non-alcoholic Steatohepatitis Development and Inflammation in Kupffer Cells Induced by Palmitic Acid
- (2017) Can Cai et al. INFLAMMATION
- CD44 is a key player in non-alcoholic steatohepatitis
- (2017) Stéphanie Patouraux et al. JOURNAL OF HEPATOLOGY
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- RORα Induces KLF4-Mediated M2 Polarization in the Liver Macrophages that Protect against Nonalcoholic Steatohepatitis
- (2017) Yong-Hyun Han et al. Cell Reports
- Obesity and Cancer: The Oil that Feeds the Flame
- (2016) Joan Font-Burgada et al. Cell Metabolism
- Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
- (2016) Eri H. Kobayashi et al. Nature Communications
- A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet
- (2016) Gabsik Yang et al. Scientific Reports
- Nrf2 is essential for the anti-inflammatory effect of carbon monoxide in LPS-induced inflammation
- (2015) SiYuan Qin et al. INFLAMMATION RESEARCH
- ATF3-Mediated NRF2/HO-1 Signaling Regulates TLR4 Innate Immune Responses in Mouse Liver Ischemia/Reperfusion Injury
- (2014) J. Rao et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease
- (2014) X. Varelas DEVELOPMENT
- A macrophage-specific synthetic promoter for therapeutic application of adiponectin
- (2014) W S Kang et al. GENE THERAPY
- The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
- (2014) John D. Hayes et al. TRENDS IN BIOCHEMICAL SCIENCES
- Role of Nrf2 in chronic liver disease
- (2014) Wei Tang WORLD JOURNAL OF GASTROENTEROLOGY
- Role of Nrf2 in Oxidative Stress and Toxicity
- (2013) Qiang Ma Annual Review of Pharmacology and Toxicology
- KEAP1-NRF2 complex in ischemia-induced hepatocellular damage of mouse liver transplants
- (2013) Bibo Ke et al. JOURNAL OF HEPATOLOGY
- The Ets Transcription Factor GABP Is a Component of the Hippo Pathway Essential for Growth and Antioxidant Defense
- (2013) Hongtan Wu et al. Cell Reports
- Kuppfer Cells Trigger Nonalcoholic Steatohepatitis Development in Diet-induced Mouse Model through Tumor Necrosis Factor-α Production
- (2012) Annie-Carole Tosello-Trampont et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inflammasomes in liver diseases
- (2012) Gyongyi Szabo et al. JOURNAL OF HEPATOLOGY
- Nrf2 the rescue: Effects of the antioxidative/electrophilic response on the liver
- (2010) Curtis D. Klaassen et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Critical role of Kupffer cells in the management of diet-induced diabetes and obesity
- (2009) Audrey M. Neyrinck et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Depletion of Liver Kupffer Cells Prevents the Development of Diet-Induced Hepatic Steatosis and Insulin Resistance
- (2009) W. Huang et al. DIABETES
- Kupffer cells promote hepatic steatosis via interleukin-1β-dependent suppression of peroxisome proliferator-activated receptor α activity
- (2009) Rinke Stienstra et al. HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started